Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: xcr600 who wrote (5938)	11/5/1998 6:44:00 AM
From: Linda Kaplan	Respond to of 7041

Sometimes the longs are given info we don't have, and they do bid up this stock in advance of news. But I've found that when the news is known it's usually meager and the stock drops! I don't think that the Mexico sales are good; I think they are awful. And sales are the key proof that Vasomax would fail even if it were approved. I think they'll try to bury the bad news about the Mexico sales with some meager announcement, like filing to sell Vasomax in Turkey. That is the sort of thing they've been doing. There was that big fuss about their filing somewhere a while ago, but no approval yet, and no SALES. If approval comes through the important question will be SALES. Mexico is the test area for that, so let's see what they show on Mexico sales. Aren't earnings do in a week or so? --Linda